CCCC
C4 Therapeutics, Inc.$2.74-0.09 (-3.18%)Prev Close$2.83·MCap$234.4M·P/E—·Vol1.46M·Yield—
▲
Buys (12M)
0
$0.00
▼
Sells (12M)
10
$243.5K
◆
Net Activity
Net Seller
$243.5K
●
Active Insiders
6
last 12 mo
Over the past 12 months, insider activity at C4 Therapeutics, Inc. (CCCC) has been exclusively selling, with 0 insider purchases totaling $0.00 and 10 insider sales totaling $243.5K. The most recent insider transaction was by Hirsch Andrew (President & CEO), who sold $91.1K worth of shares on Feb 18, 2026. C4 Therapeutics, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $234.4M.
CCCC Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Feb 18, 2026 | Hirsch Andrew | President & CEO | Sell | 48,211 | $1.89 | $91.1K | 0 |
| Feb 13, 2026 | Adams Kendra | Chief Financial Officer | Sell | 17,244 | $1.89 | $32.6K | 0 |
| Feb 13, 2026 | Boyle Scott N | Chief Business Officer | Sell | 9,004 | $1.89 | $17.0K | 0 |
| Feb 13, 2026 | Mahaney Paige | Chief Scientific Officer | Sell | 2,446 | $1.89 | $4.6K | 0 |
| Feb 13, 2026 | Mossler Mark | Chief Accounting Officer | Sell | 3,268 | $1.89 | $6.2K | 0 |
| Feb 13, 2026 | REYNO LEONARD | Chief Medical Officer | Sell | 16,579 | $1.89 | $31.3K | 0 |
| Jan 16, 2026 | REYNO LEONARD | Chief Medical Officer | Sell | 10,000 | $2.22 | $22.2K | 0 |
| Oct 28, 2025 | Mahaney Paige | Chief Scientific Officer | Sell | 5,644 | $2.58 | $14.6K | 0 |
| Sep 18, 2025 | Adams Kendra | Chief Financial Officer | Sell | 2,775 | $3.32 | $9.2K | 0 |
| Jul 10, 2025 | REYNO LEONARD | Chief Medical Officer | Sell | 7,382 | $1.99 | $14.7K | 0 |
| Feb 14, 2025 | Hirsch Andrew | President & CEO | Sell | 22,217 | $3.18 | $70.7K | 0 |
| Feb 14, 2025 | Mossler Mark | Chief Accounting Officer | Sell | 1,586 | $3.18 | $5.0K | 0 |
| Feb 14, 2025 | REYNO LEONARD | Chief Medical Officer | Sell | 5,145 | $3.18 | $16.4K | 0 |
| Feb 13, 2025 | Adams Kendra | Chief Financial Officer | Sell | 6,422 | $3.19 | $20.5K | 0 |
| Feb 13, 2025 | Boyle Scott N | Chief Business Officer | Sell | 5,262 | $3.18 | $16.7K | 0 |
| Feb 13, 2025 | Siegel Jolie | Chief Legal Officer | Sell | 5,049 | $3.19 | $16.1K | 0 |
| Nov 7, 2024 | Boyle Scott N | Chief Business Officer | Sell | 1,102 | $6.04 | $6.7K | 0 |
| Nov 7, 2024 | Hirsch Andrew | President & CEO | Sell | 5,550 | $6.04 | $33.5K | 0 |
| Sep 18, 2024 | Adams Kendra | Chief Financial Officer | Sell | 1,837 | $6.38 | $11.7K | 0 |
| Sep 16, 2024 | Boyle Scott N | Chief Business Officer | Sell | 661 | $6.36 | $4.2K | 0 |
| Sep 16, 2024 | Hirsch Andrew | President & CEO | Sell | 3,329 | $6.36 | $21.2K | 0 |
| Jul 10, 2024 | REYNO LEONARD | Chief Medical Officer | Sell | 6,191 | $5.00 | $31.0K | 0 |
| Feb 15, 2024 | Hirsch Andrew | President & CEO | Sell | 6,560 | $7.90 | $51.8K | 0 |
| Feb 13, 2024 | Adams Kendra | Chief Financial Officer | Sell | 1,301 | $6.53 | $8.5K | 0 |
| Feb 13, 2024 | Fisher Stewart | Chief Scientific Officer | Sell | 2,255 | $6.53 | $14.7K | 0 |
| Feb 13, 2024 | Siegel Jolie | Chief Legal Officer | Sell | 1,735 | $6.53 | $11.3K | 0 |
| Aug 30, 2023 | Hirsch Andrew | President & CEO | Sell | 2,205 | $2.93 | $6.5K | 0 |
| Aug 30, 2023 | Siegel Jolie | Chief Legal Officer | Sell | 661 | $2.93 | $1.9K | 0 |
| Feb 8, 2023 | Koppikar Utpal | Director | Buy | 5,667 | $5.60 | $31.7K | 0 |
| Jan 30, 2023 | Boyle Scott N | Chief Business Officer | Sell | 1,222 | $7.78 | $9.5K | 0 |
| Jan 30, 2023 | Crystal Adam | Chief Medical Officer | Sell | 1,301 | $7.78 | $10.1K | 0 |
| Jan 30, 2023 | Hirsch Andrew | President & CEO | Sell | 4,319 | $7.78 | $33.6K | 0 |
| Apr 12, 2022 | Hirsch Andrew | President & CEO | Buy | 10,000 | $8.40 | $84.0K | 0 |
| Jan 4, 2022 | Crystal Adam | Chief Medical Officer | Sell | 15,000 | $31.66 | $475.0K | 0 |
| Dec 17, 2021 | Salter Malcolm | Director | Sell | 755 | $30.25 | $22.8K | 0 |
| Nov 19, 2021 | Salter Malcolm | Director | Sell | 755 | $40.11 | $30.3K | 0 |
| Oct 15, 2021 | Salter Malcolm | Director | Sell | 755 | $44.94 | $33.9K | 0 |
| Oct 1, 2021 | Crystal Adam | Chief Medical Officer | Sell | 15,000 | $45.43 | $681.4K | 0 |
| Sep 27, 2021 | Prokupets Elena | Director | Sell | 1,850 | $50.04 | $92.6K | 0 |
| Sep 22, 2021 | Prokupets Elena | Director | Sell | 32,743 | $50.28 | $1.65M | 0 |
| Sep 17, 2021 | Prokupets Elena | Director | Sell | 21,161 | $50.09 | $1.06M | 0 |
| Sep 17, 2021 | Salter Malcolm | Director | Sell | 755 | $49.89 | $37.7K | 0 |
| Sep 14, 2021 | Prokupets Elena | Director | Sell | 81,330 | $48.78 | $3.97M | 0 |
| Sep 10, 2021 | Prokupets Elena | Director | Sell | 5,880 | $50.04 | $294.2K | 0 |
| Sep 10, 2021 | Siegel Jolie | Chief Legal Officer | Sell | 12,500 | $50.00 | $625.0K | 0 |
| Aug 20, 2021 | Salter Malcolm | Director | Sell | 755 | $40.73 | $30.8K | 0 |
| Aug 3, 2021 | Fisher Stewart | Chief Scientific Officer | Sell | 17,057 | $45.01 | $767.8K | 0 |
| Aug 3, 2021 | Prokupets Elena | Director | Sell | 14,407 | $45.16 | $650.6K | 0 |
| Jul 29, 2021 | Crystal Adam | Chief Medical Officer | Sell | 15,000 | $45.00 | $675.0K | 0 |
| Jul 29, 2021 | Fisher Stewart | Chief Scientific Officer | Sell | 68,315 | $45.00 | $3.07M | 0 |
Showing 1–50 of 57
1 / 2
CCCC Insider Buying Activity
The following table shows recent insider purchases of C4 Therapeutics, Inc. (CCCC) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Feb 8, 2023 | Koppikar Utpal | Director | Buy | 5,667 | $5.60 | $31.7K | 0 |
| Apr 12, 2022 | Hirsch Andrew | President & CEO | Buy | 10,000 | $8.40 | $84.0K | 0 |
CCCC Insider Selling Activity
The following table shows recent insider sales of C4 Therapeutics, Inc. (CCCC) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Feb 18, 2026 | Hirsch Andrew | President & CEO | Sell | 48,211 | $1.89 | $91.1K | 0 |
| Feb 13, 2026 | Adams Kendra | Chief Financial Officer | Sell | 17,244 | $1.89 | $32.6K | 0 |
| Feb 13, 2026 | Boyle Scott N | Chief Business Officer | Sell | 9,004 | $1.89 | $17.0K | 0 |
| Feb 13, 2026 | Mahaney Paige | Chief Scientific Officer | Sell | 2,446 | $1.89 | $4.6K | 0 |
| Feb 13, 2026 | Mossler Mark | Chief Accounting Officer | Sell | 3,268 | $1.89 | $6.2K | 0 |
| Feb 13, 2026 | REYNO LEONARD | Chief Medical Officer | Sell | 16,579 | $1.89 | $31.3K | 0 |
| Jan 16, 2026 | REYNO LEONARD | Chief Medical Officer | Sell | 10,000 | $2.22 | $22.2K | 0 |
| Oct 28, 2025 | Mahaney Paige | Chief Scientific Officer | Sell | 5,644 | $2.58 | $14.6K | 0 |
| Sep 18, 2025 | Adams Kendra | Chief Financial Officer | Sell | 2,775 | $3.32 | $9.2K | 0 |
| Jul 10, 2025 | REYNO LEONARD | Chief Medical Officer | Sell | 7,382 | $1.99 | $14.7K | 0 |
| Feb 14, 2025 | Hirsch Andrew | President & CEO | Sell | 22,217 | $3.18 | $70.7K | 0 |
| Feb 14, 2025 | Mossler Mark | Chief Accounting Officer | Sell | 1,586 | $3.18 | $5.0K | 0 |
| Feb 14, 2025 | REYNO LEONARD | Chief Medical Officer | Sell | 5,145 | $3.18 | $16.4K | 0 |
| Feb 13, 2025 | Adams Kendra | Chief Financial Officer | Sell | 6,422 | $3.19 | $20.5K | 0 |
| Feb 13, 2025 | Boyle Scott N | Chief Business Officer | Sell | 5,262 | $3.18 | $16.7K | 0 |
| Feb 13, 2025 | Siegel Jolie | Chief Legal Officer | Sell | 5,049 | $3.19 | $16.1K | 0 |
| Nov 7, 2024 | Boyle Scott N | Chief Business Officer | Sell | 1,102 | $6.04 | $6.7K | 0 |
| Nov 7, 2024 | Hirsch Andrew | President & CEO | Sell | 5,550 | $6.04 | $33.5K | 0 |
| Sep 18, 2024 | Adams Kendra | Chief Financial Officer | Sell | 1,837 | $6.38 | $11.7K | 0 |
| Sep 16, 2024 | Boyle Scott N | Chief Business Officer | Sell | 661 | $6.36 | $4.2K | 0 |
| Sep 16, 2024 | Hirsch Andrew | President & CEO | Sell | 3,329 | $6.36 | $21.2K | 0 |
| Jul 10, 2024 | REYNO LEONARD | Chief Medical Officer | Sell | 6,191 | $5.00 | $31.0K | 0 |
| Feb 15, 2024 | Hirsch Andrew | President & CEO | Sell | 6,560 | $7.90 | $51.8K | 0 |
| Feb 13, 2024 | Adams Kendra | Chief Financial Officer | Sell | 1,301 | $6.53 | $8.5K | 0 |
| Feb 13, 2024 | Fisher Stewart | Chief Scientific Officer | Sell | 2,255 | $6.53 | $14.7K | 0 |
| Feb 13, 2024 | Siegel Jolie | Chief Legal Officer | Sell | 1,735 | $6.53 | $11.3K | 0 |
| Aug 30, 2023 | Hirsch Andrew | President & CEO | Sell | 2,205 | $2.93 | $6.5K | 0 |
| Aug 30, 2023 | Siegel Jolie | Chief Legal Officer | Sell | 661 | $2.93 | $1.9K | 0 |
| Jan 30, 2023 | Boyle Scott N | Chief Business Officer | Sell | 1,222 | $7.78 | $9.5K | 0 |
| Jan 30, 2023 | Crystal Adam | Chief Medical Officer | Sell | 1,301 | $7.78 | $10.1K | 0 |
| Jan 30, 2023 | Hirsch Andrew | President & CEO | Sell | 4,319 | $7.78 | $33.6K | 0 |
| Jan 4, 2022 | Crystal Adam | Chief Medical Officer | Sell | 15,000 | $31.66 | $475.0K | 0 |
| Dec 17, 2021 | Salter Malcolm | Director | Sell | 755 | $30.25 | $22.8K | 0 |
| Nov 19, 2021 | Salter Malcolm | Director | Sell | 755 | $40.11 | $30.3K | 0 |
| Oct 15, 2021 | Salter Malcolm | Director | Sell | 755 | $44.94 | $33.9K | 0 |
| Oct 1, 2021 | Crystal Adam | Chief Medical Officer | Sell | 15,000 | $45.43 | $681.4K | 0 |
| Sep 27, 2021 | Prokupets Elena | Director | Sell | 1,850 | $50.04 | $92.6K | 0 |
| Sep 22, 2021 | Prokupets Elena | Director | Sell | 32,743 | $50.28 | $1.65M | 0 |
| Sep 17, 2021 | Prokupets Elena | Director | Sell | 21,161 | $50.09 | $1.06M | 0 |
| Sep 17, 2021 | Salter Malcolm | Director | Sell | 755 | $49.89 | $37.7K | 0 |
| Sep 14, 2021 | Prokupets Elena | Director | Sell | 81,330 | $48.78 | $3.97M | 0 |
| Sep 10, 2021 | Prokupets Elena | Director | Sell | 5,880 | $50.04 | $294.2K | 0 |
| Sep 10, 2021 | Siegel Jolie | Chief Legal Officer | Sell | 12,500 | $50.00 | $625.0K | 0 |
| Aug 20, 2021 | Salter Malcolm | Director | Sell | 755 | $40.73 | $30.8K | 0 |
| Aug 3, 2021 | Fisher Stewart | Chief Scientific Officer | Sell | 17,057 | $45.01 | $767.8K | 0 |
| Aug 3, 2021 | Prokupets Elena | Director | Sell | 14,407 | $45.16 | $650.6K | 0 |
| Jul 29, 2021 | Crystal Adam | Chief Medical Officer | Sell | 15,000 | $45.00 | $675.0K | 0 |
| Jul 29, 2021 | Fisher Stewart | Chief Scientific Officer | Sell | 68,315 | $45.00 | $3.07M | 0 |
CCCC Insiders
Similar Stocks to CCCC
VRTX
Vertex Pharmaceuticals Incorporated
$429.47+0.81%
$111.71B
REGN
Regeneron Pharmaceuticals, Inc.
$734.06-1.39%
$77.87B
ALNY
Alnylam Pharmaceuticals, Inc.
$303.44-1.64%
$41.24B
INSM
Insmed Incorporated
$135.11-0.64%
$30.79B
RVMD
Revolution Medicines, Inc.
$144.62+9.92%
$29.51B
UTHR
United Therapeutics Corporation
$566.69+0.03%
$25.13B
MRNA
Moderna, Inc.
$47.16-3.17%
$21.42B
RPRX
Royalty Pharma plc
$49.40-0.50%
$21.20B